The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results (Q73280037)
scientific article published on 01 March 1997
Language:
(P31) (Q13442814)
(P304) 46-55
(P407) (Q1860)
(P433) 3A Suppl
(P478) 49
(P577) Saturday, March 1, 1997
(P1433) (Q7900884)
(P1476) "The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results" (language: en)
(P2093) W R Fair
M S Cookson
N Stroumbakis
D Cohen
A G Aprikian
Y Wang
P Russo
S M Soloway
P Sogani
J Sheinfeld
H Herr
G Dalgabni
C B Begg
W D Heston
V E Reuter
(P2860) (Q50610104)
(Q34291551)
(Q40190517)
(Q71252256)
(Q71606146)
(Q67532202)
(Q67689995)
(Q68589926)
(Q68072733)
(Q42475394)
(Q67833871)
(Q72069092)
(Q39228930)
(Q72073904)
(Q71612095)
(Q39370835)
(Q93863823)
(Q46269663)
(Q71567201)
(Q68215966)
(Q34719575)
(Q71651714)
(Q53656412)
(Q71651731)
(Q39370552)
other details
description scientific article published on 01 March 1997

External Links